Company profile

Alkermes plc. Insider Trading

ALKS

Every SEC Form 4 insider trading filing for Alkermes plc. (ALKS) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001520262
Filings
201
Insiders
20
Last filing
2026-08-17

Activity summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares versus 1 sale. Buying was led by snyderman nancy lynn MD.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. Alkermes plc. insiders were net sellers in every quarter shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $21.8M.

90 day insight

Over the last 90 days, Alkermes plc. insiders bought $2.4M (10 transactions) and sold $2.9M (2 transactions).

  • Most active insider: Hopkinson Craig C. with 12 transactions totaling $1.6M.
  • Largest single sale: $2.2M by snyderman nancy lynn MD on Aug 3, 2026.
  • 83% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 17, 2026Nichols Christian ToddALKS
Sale10b5
6,912$49.19$340K
Aug 17, 2026Nichols Christian ToddALKS
Sale10b5
664$49.65$33K
Aug 5, 2026Jackson Blair CurtisALKS
Award
124,305
Aug 5, 2026Jackson Blair CurtisALKS
Award
93,229
Aug 3, 2026snyderman nancy lynn MDALKS
Option Exercise
27,948

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=ALKS" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

snyderman nancy lynn MDDirector4 filings$216K
Hopkinson Craig C.EVP R&D, Chief Medical Officer8 filings$960K
Parisi Samuel JosephVP, Finance (Interim PAO)3 filings$371K
Nichols Christian ToddSVP, Chief Commercial Officer2 filings$373K
Gaffin David JosephEVP, CLO, Alkermes, Inc.3 filings$296K